Richard Faint

758 total citations
17 papers, 556 citations indexed

About

Richard Faint is a scholar working on Hematology, Molecular Biology and Cancer Research. According to data from OpenAlex, Richard Faint has authored 17 papers receiving a total of 556 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Hematology, 6 papers in Molecular Biology and 6 papers in Cancer Research. Recurrent topics in Richard Faint's work include Protease and Inhibitor Mechanisms (6 papers), Blood Coagulation and Thrombosis Mechanisms (5 papers) and Blood properties and coagulation (3 papers). Richard Faint is often cited by papers focused on Protease and Inhibitor Mechanisms (6 papers), Blood Coagulation and Thrombosis Mechanisms (5 papers) and Blood properties and coagulation (3 papers). Richard Faint collaborates with scholars based in United Kingdom, United States and France. Richard Faint's co-authors include Peter Charlton, Samuel J. Machin, Justin S. Bryans, Ian Mackie, Adrian Folkes, Sukhjit Sohal, Paul Bevan, Robin W. Carrell, Aiwu Zhou and David A. Lomas and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Immunology and Nature Reviews Drug Discovery.

In The Last Decade

Richard Faint

17 papers receiving 521 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Richard Faint United Kingdom 13 193 181 175 87 84 17 556
Andrea Schweinitz Germany 13 299 1.5× 141 0.8× 230 1.3× 91 1.0× 151 1.8× 23 620
Gary R. Sitko United States 16 125 0.6× 369 2.0× 67 0.4× 149 1.7× 55 0.7× 29 756
E Frankus Germany 8 282 1.5× 211 1.2× 308 1.8× 20 0.2× 104 1.2× 21 773
Éva Barabás United States 12 248 1.3× 216 1.2× 89 0.5× 100 1.1× 160 1.9× 49 634
Sandeep Batra United States 10 274 1.4× 170 0.9× 80 0.5× 113 1.3× 134 1.6× 38 689
Hollis R. Williams United States 12 337 1.7× 55 0.3× 179 1.0× 71 0.8× 155 1.8× 15 810
Janey N. Parsons United States 9 384 2.0× 51 0.3× 73 0.4× 58 0.7× 126 1.5× 10 691
Rudolf Mihalik Hungary 16 535 2.8× 58 0.3× 95 0.5× 33 0.4× 206 2.5× 58 846
Christophe Henry France 12 160 0.8× 54 0.3× 39 0.2× 100 1.1× 158 1.9× 25 459
Mary Gleason-Guzman United States 13 589 3.1× 65 0.4× 53 0.3× 92 1.1× 233 2.8× 15 813

Countries citing papers authored by Richard Faint

Since Specialization
Citations

This map shows the geographic impact of Richard Faint's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard Faint with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard Faint more than expected).

Fields of papers citing papers by Richard Faint

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard Faint. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard Faint. The network helps show where Richard Faint may publish in the future.

Co-authorship network of co-authors of Richard Faint

This figure shows the co-authorship network connecting the top 25 collaborators of Richard Faint. A scholar is included among the top collaborators of Richard Faint based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard Faint. Richard Faint is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Faint, Richard, Ian Mackie, & S.J. Machin. (2008). Platelet aggregation is inhibited by a nitric oxide-like factor released from human neutrophils in vitro. British Journal of Haematology. 77(4). 539–545. 7 indexed citations
2.
Faint, Richard, et al.. (2005). Therapeutic cancer vaccines. Nature Reviews Drug Discovery. 4(8). 623–624. 26 indexed citations
3.
Wang, Shouming, Adrian Folkes, Irina Chuckowree, et al.. (2004). Studies on Pyrrolopyrimidines as Selective Inhibitors of Multidrug-Resistance- Associated Protein in Multidrug Resistance. Journal of Medicinal Chemistry. 47(6). 1329–1338. 69 indexed citations
4.
Wang, Shouming, Hamish Ryder, Paul Depledge, et al.. (2002). Studies on Quinazolinones as Dual Inhibitors of Pgp and MRP1 in Multidrug Resistance. Bioorganic & Medicinal Chemistry Letters. 12(4). 571–574. 32 indexed citations
5.
Zhou, Aiwu, Richard Faint, Peter Charlton, et al.. (2001). Polymerization of Plasminogen Activator Inhibitor-1. Journal of Biological Chemistry. 276(12). 9115–9122. 52 indexed citations
6.
Folkes, Adrian, Michael B. Roe, Sukhjit Sohal, et al.. (2001). Synthesis and in vitro evaluation of a series of diketopiperazine inhibitors of plasminogen activator inhibitor-1. Bioorganic & Medicinal Chemistry Letters. 11(19). 2589–2592. 47 indexed citations
7.
8.
Charlton, Peter, Richard Faint, Adrian Folkes, et al.. (1997). XR5118, a novel modulator of plasminogen activator inhibitor-1 (PAI-1), increases endogenous tPA activity in the rat. Fibrinolysis & proteolysis. 11(1). 51–56. 24 indexed citations
9.
Bryans, Justin S., et al.. (1996). Inhibition of Plasminogen Activator Inhibitor-1 Activity by Two Diketopiperazines, XR330 and XR334 Produced by Streptomyces sp.. The Journal of Antibiotics. 49(10). 1014–1021. 50 indexed citations
10.
Faint, Richard, Paul Bevan, Justin S. Bryans, et al.. (1996). P55. Plasminogen activator inhibitor-1. Blood Coagulation & Fibrinolysis. 7(3). 410–410. 1 indexed citations
11.
Charlton, Peter, Richard Faint, Justin S. Bryans, et al.. (1996). Evaluation of a Low Molecular Weight Modulator of Human Plasminogen Activator Inhibitor-1 Activity. Thrombosis and Haemostasis. 75(5). 808–815. 66 indexed citations
12.
Harrison, Paul, Barry Wilbourn, Elisabeth M. Cramer, et al.. (1992). The influence of therapeutic blocking of Gp IIb/IIIa on platelet α‐granular fibrinogen. British Journal of Haematology. 82(4). 721–728. 18 indexed citations
13.
Faint, Richard. (1992). Platelet—neutrophil interactions: Their significance. Blood Reviews. 6(2). 83–91. 96 indexed citations
14.
Roberts, Pamela, Vinod Devalia, Richard Faint, et al.. (1991). Differentiation-linked activation of the respiratory burst in a monocytic cell line (U937) via Fc gamma RII. A study of activation pathways and their regulation. The Journal of Immunology. 147(9). 3104–3115. 21 indexed citations
15.
Gordge, M.P., Amit Patel, Richard Faint, P B Rylance, & Guy H. Neild. (1990). Blood Hyperviscosity and Its Relationship to Progressive Renal Failure in Patients with Diabetic Nephropathy. Diabetic Medicine. 7(10). 880–886. 14 indexed citations
16.
Cummins, David, et al.. (1990). A Plasma Inhibitor of Platelet Aggregation in Patients with Argentine Hemorrhagic Fever. American Journal of Tropical Medicine and Hygiene. 42(5). 470–475. 23 indexed citations
17.
Gordge, M.P., Richard Faint, P B Rylance, & Guy H. Neild. (1988). Abnormal Blood Rheology in Progressive Renal Failure: A Factor in Non-immune Glomerular Injury?. Nephrology Dialysis Transplantation. 3(3). 257–262. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Andrea Schweinitz Breakdown of academic impact, for papers by Gary R. Sitko Breakdown of academic impact, for papers by E Frankus Breakdown of academic impact, for papers by Éva Barabás Breakdown of academic impact, for papers by Sandeep Batra Breakdown of academic impact, for papers by Hollis R. Williams Breakdown of academic impact, for papers by Janey N. Parsons Breakdown of academic impact, for papers by Rudolf Mihalik Breakdown of academic impact, for papers by Christophe Henry Breakdown of academic impact, for papers by Mary Gleason-Guzman
Rankless by CCL
2026